semaglutide 2mg vial Well Brain Body | Virtual

This study is recruiting participants to test the effectiveness of CT-868, a new investigational medication for blood sugar management being tested in people with type 1 diabetes and obesity.

Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.

Trusted medical solutions for fast, effective results.

Regain Control with Plant-Powered Balance

Unlock lasting weight loss with Calibrate's clinically-led Metabolic Reset

This "skinny fat" outcome leads to a crashed metabolic rate and an increased risk of weight regain, known as the "rebound" effect